About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 110 record(s)
Req # A-2021-00815
Copies of all emails to/from cc'ing Guillaume Coullaird regarding the use of the excessive prices penalty and future use against pharmaceutical companies from January 1, 2019 to January 18, 2021.Organization: Patented Medicine Prices Review Board Canada
February 2021
Req # A-2021-01073
Copies of all emails to/from and cc'ing Douglas Clark, Mitchell Levine and Melanie Bourassa-Forcier regarding the decision to delay the implementation of the PMPRB guidelines to Summer 2021 from November 1, 2020 to January 20, 2021.Organization: Patented Medicine Prices Review Board Canada
February 2021
Req # A-2021-01083
Copies of all emails to/from and cc'ing Douglas Clark, Mitchell Levine and Melanie Bourassa-Forcier regarding any directives from the Health minister's office regarding the implementation of the new PMPRB guidelines from January 1, 2020 to…Organization: Patented Medicine Prices Review Board Canada
February 2021
Req # A-2020-18435
All briefing notes, memos, PowerPoints, policy briefs and reports submitted to the ISED Minister from June 1, 2019 to November 19, 2020.Organization: Patented Medicine Prices Review Board Canada
December 2020
Req # A-2020-18732
A detailed summary of the PMPRB's use of the excessive price penalty on pharmaceutical companies from June 1, 2019 to November 26, 2020. For each penalty, break it down by date, company charged, drug in question, and fine levied.Organization: Patented Medicine Prices Review Board Canada
December 2020
Req # A-2020-09098
Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back…Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A 2020_0004
Information on any and all monies given to Canada’s top 40 electrical companies in the name of COVID-19. Monies paid in the name of COVID-19 between the dates January 1, 2020 to present date. Any and all monies paid or loaned out in the name of…Organization: Canada Development Investment Corporation
July 2020
Req # A 2019_0019
Please provide the December 2019 and/or the January 2020 agendas that Stephen Swaffield received for the Board of Directors of the TransMountain Corporation. Please include any appendices and minutes.Organization: Canada Development Investment Corporation
March 2020
Req # A 2019_0014
Please provide any briefing notes, agendas and any attachments, appendices for CDEV Chair Stephen Swaffield’s meeting with the Trans Mountain Corporation Board of Directors for September 2019.Organization: Canada Development Investment Corporation
January 2020
Req # A 2019_0012
Please provide any briefing notes, agendas and any attachments, appendices for CDEV Chair Stephen Swaffield’s meeting with the Trans Mountain Corporation Board of Directors for October 2019.Organization: Canada Development Investment Corporation
January 2020